Dose dependent augmentation of neuroplasticity-based auditory learning in schizophrenia: a double-blind, placebo-controlled, randomized, target engagement clinical trial of the N-methyl-D-aspartate-type glutamate receptor (NMDAR) agonist d-serine
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose dependent augmentation of neuroplasticity-based auditory learning in schizophrenia: a double-blind, placebo-controlled, randomized, target engagement clinical trial of the N-methyl-D-aspartate-type glutamate receptor (NMDAR) agonist d-serine
Authors
Keywords
-
Journal
BIOLOGICAL PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-01-28
DOI
10.1016/j.biopsych.2023.01.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease
- (2022) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- Challenges and Strategies for the Recruitment of Patients With Schizophrenia in a Research Setting
- (2022) Elizabeth Deckler et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
- (2021) Kah Kheng Goh et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia
- (2021) Yash B. Joshi et al. AMERICAN JOURNAL OF PSYCHIATRY
- D-Serine: A Cross Species Review of Safety
- (2021) Amir Meftah et al. Frontiers in Psychiatry
- Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058
- (2021) Pejman Sehatpour et al. NEUROPSYCHOPHARMACOLOGY
- Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia
- (2020) Andrew D. Krystal et al. NATURE MEDICINE
- Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia
- (2020) Juan L. Molina et al. Biological Psychiatry-Cognitive Neuroscience and Neuroimaging
- Memantine effects on auditory discrimination and training in schizophrenia patients
- (2020) Neal R. Swerdlow et al. NEUROPSYCHOPHARMACOLOGY
- A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-d-aspartate receptor blockade in healthy veterans
- (2020) Nicholas Murphy et al. NEUROPSYCHOPHARMACOLOGY
- Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia
- (2019) Alice Medalia et al. SCHIZOPHRENIA RESEARCH
- A Randomized Controlled Trial of Executive Functioning Training Compared With Perceptual Training for Schizophrenia Spectrum Disorders: Effects on Neurophysiology, Neurocognition, and Functioning
- (2019) Michael W. Best et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mismatch negativity reveals plasticity in cortical dynamics after 1-hour of auditory training exercises
- (2019) Veronica B. Perez et al. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
- Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia
- (2019) Clément Dondé et al. Translational Psychiatry
- Neural and functional correlates of impaired reading ability in schizophrenia
- (2019) Clément Dondé et al. Scientific Reports
- Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
- (2019) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- The plastic d -serine signaling pathway: Sliding from neurons to glia and vice-versa
- (2018) Andrei D. Ivanov et al. NEUROSCIENCE LETTERS
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
- (2018) Daniel C. Javitt et al. JAMA Psychiatry
- Association between increased serum d -serine and cognitive gains induced by intensive cognitive training in schizophrenia
- (2018) Rogerio Panizzutti et al. SCHIZOPHRENIA RESEARCH
- N -methyl- d -aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
- (2018) Joshua T. Kantrowitz SCHIZOPHRENIA RESEARCH
- Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge
- (2018) Neal R. Swerdlow et al. SCHIZOPHRENIA RESEARCH
- The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
- (2018) Andrew D. Krystal et al. NATURE REVIEWS DRUG DISCOVERY
- Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia
- (2018) William C. Hochberger et al. NEUROPSYCHOPHARMACOLOGY
- Neural mechanisms of mismatch negativity dysfunction in schizophrenia
- (2017) M Lee et al. MOLECULAR PSYCHIATRY
- Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia
- (2017) Veronica B Perez et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia
- (2017) Eduardo Dunayevich et al. SCHIZOPHRENIA RESEARCH
- Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia
- (2017) Michael L. Thomas et al. JAMA Psychiatry
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia
- (2017) Michael Avissar et al. SCHIZOPHRENIA RESEARCH
- Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
- (2016) Joshua T. Kantrowitz et al. BRAIN
- The effects of ketamine on the mismatch negativity (MMN) in humans – A meta-analysis
- (2016) Timm Rosburg et al. CLINICAL NEUROPHYSIOLOGY
- A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing–Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder
- (2016) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Post-Movement Beta Activity in Sensorimotor Cortex Indexes Confidence in the Estimations from Internal Models
- (2016) Huiling Tan et al. JOURNAL OF NEUROSCIENCE
- Low d-serine levels in schizophrenia: A systematic review and meta-analysis
- (2016) Seo-Eun Cho et al. NEUROSCIENCE LETTERS
- Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia
- (2015) Gregory A. Light et al. Annals of the New York Academy of Sciences
- The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
- (2015) Darrick T Balu et al. CURRENT OPINION IN PHARMACOLOGY
- Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia
- (2015) J. T. Kantrowitz et al. JOURNAL OF NEUROSCIENCE
- Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis
- (2015) Neal R Swerdlow et al. NEUROPSYCHOPHARMACOLOGY
- Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective
- (2015) C. M. Corcoran et al. PSYCHOLOGICAL MEDICINE
- The NIMH experimental medicine initiative
- (2015) Thomas R. Insel World Psychiatry
- Reading Deficits in Schizophrenia and Individuals at High Clinical Risk: Relationship to Sensory Function, Course of Illness, and Psychosocial Outcome
- (2014) Nadine Revheim et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mismatch Negativity (MMN) as an Index of Cognitive Dysfunction
- (2014) Risto Näätänen et al. BRAIN TOPOGRAPHY
- Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction
- (2014) Darrick T. Balu et al. NEUROCHEMISTRY INTERNATIONAL
- d-Cycloserine augmentation of cognitive remediation in schizophrenia
- (2014) Christopher K. Cain et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior
- (2013) David-Marian Otte et al. PLoS One
- Auditory Emotion Recognition Impairments in Schizophrenia: Relationship to Acoustic Features and Cognition
- (2012) Rinat Gold et al. AMERICAN JOURNAL OF PSYCHIATRY
- Extensive stimulus repetition leads older adults to show delayed functional magnetic resonance imaging adaptation
- (2012) Makoto Miyakoshi et al. Brain Imaging and Behavior
- Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth Factor β Signaling through Modulation of d-Serine Levels in Cerebral Cortex Neurons
- (2012) Luan Pereira Diniz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Expectancy-related modulations of neural oscillations in continuous performance tasks
- (2012) S. Bickel et al. NEUROIMAGE
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Not Pitch Perfect: Sensory Contributions to Affective Communication Impairment in Schizophrenia
- (2011) David I. Leitman et al. BIOLOGICAL PSYCHIATRY
- Spectrotemporal dynamics of auditory cortical synaptic receptive field plasticity
- (2011) Robert C. Froemke et al. HEARING RESEARCH
- Reduction in Tonal Discriminations Predicts Receptive Emotion Processing Deficits in Schizophrenia and Schizoaffective Disorder
- (2011) Joshua T. Kantrowitz et al. SCHIZOPHRENIA BULLETIN
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- The treatment of cognitive impairment in schizophrenia
- (2010) Donald C. Goff et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Influence of Perceptual Training on Working Memory in Older Adults
- (2010) Anne S. Berry et al. PLoS One
- Recovery of functional and structural age-related changes in the rat primary auditory cortex with operant training
- (2010) E. de Villers-Sidani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Getting the Cue: Sensory Contributions to Auditory Emotion Recognition Impairments in Schizophrenia
- (2008) D. I. Leitman et al. SCHIZOPHRENIA BULLETIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started